| Patient Demographics |
| Male gender |
87% |
94% |
| Black or Hispanic |
58% ** |
74% ** |
| Mean age (years) |
49.4 |
47.7 |
| At least some college education |
58% |
65% |
| Stability of HIV |
| Mean CD4 count (mm3) |
485 * |
403 * |
| CD4 < 200 |
9% ** |
22%** |
| Mean log10 HIV RNA (copies/ml) |
2.21 ** |
2.61 ** |
| Undetectable HIV RNA |
81% * |
67% * |
| On ART |
93% |
94% |
| HCV Disease Stage |
| HCV genotype 1 or 4 |
76% |
86% |
| Mean log10 HCV RNA (copies/ml) |
6.15 |
5.90 |
| Mean AST/ALT (IU/L) |
0.97 |
0.97 |
| Mean ANC (cells/mm3) |
1059 |
1765 |
| Mean hemoglobin (g/dL) |
14.1 |
13.9 |
| Psychosocial Functioning |
| On depression treatment, if depressed |
28% ** |
7% ** |
| Frequent alcohol use (past 6 months) |
10% |
17% |
| Any illicit drug use (past 6 months) |
17% |
24% |
| Any IVDU history |
60% |
52% |
| Any missed ART doses (past week) |
27% |
31% |
| Any missed clinic appointments (past 6 months) |
34% |
26% |
| HCV knowledge |
1.70 ** |
1.26 ** |
| Provider Characteristics |
| Male gender |
32% *** |
55% *** |
| Caucasian |
42% |
45% |
| Number of co-infected patients |
244.8 |
214.9 |
| Number of patients treated with INF/RBV |
40.5 |
34.9 |
| Treat only if drug use treated and in remission |
48% * |
65% * |
| Treat only if depression treated and in remission |
54% |
63% |
| Years in practice at study clinic |
12.3 ** |
9.9 ** |
| Number of patient seen weekly |
36.9 ** |
5.3 ** |
| Perceived challenges to optimal HCV care |
1.78 * |
1.96 * |
| Threshold for patient treatment readiness |
2.60 ** |
2.90 ** |
